Aug. 20, 2009 (Baystreet.ca) --
Crystal Research Associates has published a new research report on BELLUS Health Inc.. The full report is available at: http://www.baystreet.ca/articles/research_reports/research_reports.aspx.
BayStreet.ca Research Alert: BELLUS Health Inc.
Earlier from BELLUS Health
- BELLUS Health reports results for first half of fiscal 2009
- VIVIMIND(TM) granted certificate of free sale as food supplement in Italy - Premarket notification filed in the U.S.
- BELLUS Health Inc. Announces Record Date for $12 Million Rights Offering To Common Shareholders
- BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders
- BELLUS Sante annonce que les resultats exploratoires publies dans une revue revisee par des pairs revelent que le tramiprosate ralentit l'atrophie de l'hippocampe cerebral et presentent des preuves preliminaires d'effets benefiques sur la cognition
Later from BELLUS Health
- BELLUS Health announces results of rights offering
- TSX Delisting Review - BELLUS Health Inc. (BLU)
- BELLUS Health reports results for third quarter of fiscal 2009
- BELLUS Santé annonce ses résultats pour le troisieme trimestre de 2009
- Roberto Bellini nommé Président et chef de la direction de BELLUS Santé - Francesco Bellini demeure président du conseil; Charles Cavell nommé vice-président du conseil
Follow BELLUS Health into a list and get an email when it puts out news.
Follow BELLUS Health